Press Releases
 
Singapore eDevelopment Subsidiary, Global BioLife, Presents Parkinson's Research at Neuroscience2018

SINGAPORE, 7 November 2018 -- (ACN Newswire) -- Singapore Exchange-listed Singapore eDevelopment Limited (Stock Code 40V) ("SeD"), through its subsidiary, Global BioLife Inc. ("Global BioLife") is pleased to announce that research of their promising drug platform, Linebacker, will be presented at Neuroscience 2018, the Annual Meeting for the International Society for Neuroscience (SfN) in San Diego, California.

SeD said the presentation titled, "Myricetin derivatives ameliorate deficits in 6-OHDA animal model of Parkinson's disease," will detail the results of an Integrated Drug Discovery program at Charles River Discovery Service covering Pharmacokinetics, Maximum Toxicity Dose, and an in vivo animal model of Parkinson's Disease. In essence the drug has been designed to work better than current treatments and has performed as well or better in animal models.

"More than 10 million people around the world have Parkinson's Disease," said Dr. Roscoe M. Moore, Jr., former Senior Assistant Surgeon General of the United States and Global BioLife's Chief Scientific Advisor. He also commented that "the team's unique approach to drug development is key to this success."

"We are extremely pleased and hopeful with the initial results of Linebacker and what the data shows for the potential treatment of central nervous system ("CNS") diseases. Linebacker is a direct response to the global need for effective and affordable cures," said Dr. Peihong Tang, Global BioLife's Director and Chief Executive Officer.

"We're excited to have received validating laboratory data of our Linebacker pharmaceuticals," said Mr. Daryl Thompson, Global BioLife's Director of Scientific Initiatives and inventor of the compounds. "This data proves our unique approach to CNS diseases could be a much-needed solution and could ease widespread suffering globally."

With almost 36,000 members, the Society for Neuroscience is the world's largest organisation of scientists and physicians devoted to understanding the brain and the nervous system. Selection for inclusion in this prestigious event is indicative of the compelling results generated by this research.

The abstract for this presentation can be accessed here: https://bit.ly/2yYbA79

About Singapore eDevelopment Limited

Incorporated on 9 September 2009 and listed on the Singapore Exchange in July 2010, Singapore eDevelopment Limited is involved in (i) property development and investments primarily in the United States and Western Australia; (ii) information technology-related businesses; (iii) development, research, testing, manufacturing, licensing and distribution of biomedical products; and (iv) investment activities. For more information, please visit: http://www.SeD.com.sg or email .

About Global BioLife Inc.

Global BioLife Inc. ("GBLI") is a 70%-held direct subsidiary of Global BioMedical Inc., which is a whollyowned direct subsidiary of Singapore BioMedical Pte. Ltd., which in turn is a wholly-owned direct subsidiary of Singapore eDevelopment Limited, a company listed on the Singapore Exchange. The remaining shareholding of Global BioLife Inc. is held by Global Research and Discovery Group Scientific LLC ("GRDGS") at 20% and Australian Exchange-listed Holista CollTech Limited ("Holista") at 10%.

With an aging population and a growing focus in healthcare issues, biomedical science has become increasingly vital. GBLI strives to leverage its scientific know-how and intellectual property rights to provide solutions that have been plaguing the biomedical field for decades. By tapping into the scientific expertise of GRDGS and Holista, GBLI pledges to undertake a concerted effort in the R&D, drug discovery and development for the prevention, inhibition and treatment of neurological, oncology and immuno-related diseases. GBLI is also collaborating with its partners to develop second generation mosquito defense technologies, which are DEET alternatives, to protect against mosquito transmitted diseases such as Zika and Dengue. For more information, please visit: http://www.globalbiolife.com.

This Media Release has been prepared by the Company and its contents have been reviewed by the Company's Sponsor, Hong Leong Finance Limited (the "Sponsor"), for compliance with the relevant rules of the Singapore Exchange Securities Trading Limited (the "SGX-ST"). The Sponsor has not independently verified the contents of this Media Release.

This Media Release has not been examined or approved by SGX-ST. The Sponsor and the SGX-ST assume no responsibility for the contents of this Media Release, including the correctness of any of the statements or opinions made or reports contained in this Media Release.

The contact person for the Sponsor is Mr Tang Yeng Yuen, Vice President, Head of Corporate Finance, Hong Leong Finance Limited, at 16 Raffles Quay, #01-05 Hong Leong Building, Singapore 048581, telephone: +65 6415 9886.

# # #


Submitted by ACN Newswire, ACN Newswire on Wednesday, 7 November 2018 at 8:11 PM
Category: Health Care & Medical
 
Related News

Veterinary Intravenous Solutions Market Explosive Growth Showing No Signs of Slowing Down
Thursday, 15 Nov 2018

Buy, Sell Or Rent a Medfusion 3500 Syringe Pump Today
Thursday, 15 Nov 2018

Micropipette Market Size, Growth, Trends, and Outlook 2017-2025
Thursday, 15 Nov 2018

Why You Should Purchase a Used Baxter Sigma Spectrum Infusion Pump
Thursday, 15 Nov 2018

Find a Curlin 6000 CMS PCA Infusion Pump Today
Thursday, 15 Nov 2018

Related Events

Birth Congress - Clinical Challenges in Labor and Delivery
Wednesday, 14 Nov 2018

NeoAg Summit
Wednesday, 14 Nov 2018

2nd Microbiome Movement – Gut-Brain Axis 2018
Wednesday, 14 Nov 2018

Chemical Engineering: What Scientists and other Engineers need to know
Wednesday, 14 Nov 2018

American College of Allergy, Asthma & Immunology Annual Scientific Meeting
Thursday, 15 Nov 2018

Latest News

Escort UK- For The Fantastic Night
Thursday, 15 Nov 2018

Relieve Your Stress By Utilizing Sivan Weinstein Art Therapy Services
Thursday, 15 Nov 2018

What To Expect From Escorts Service London?
Thursday, 15 Nov 2018

Escorts Of London - They Are Hot And Honest
Thursday, 15 Nov 2018

How To Deal With The Escorts In London?
Thursday, 15 Nov 2018

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Thursday, 15 November 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • The Commercial UAV Show UK 2018
  • NeoAg Summit
  • 19th Annual Ship Finance Forum - Ships and Money
  • Birth Congress - Clinical Challenges in Labor and Delivery
  • 2nd Microbiome Movement – Gut-Brain Axis 2018

  • Latest Jobs
    Sorry, there are currently no entries posted here.